News archives

2009

• December 2, 2009: Upsher-Smith Announces Milestone in Development of CNS Strategy: USL255 (Extended Release Topiramate) Entering Late-Stage Clinical Development for Epilepsy
  
  
• October 19, 2009: Danny Cottrell Named 2009 NCPA Willard B. Simmons Independent Pharmacist of the Year.
  
  
• May 4, 2009: AmLactin^® Family of Moisturizers Has a New Look
  
  
• April 3, 2009: Common Skin Condition May Have 40% of Americans Asking, “What Are Those Little Red Bumps?”
  
  
• April 3, 2009: New AmLactin^® Foot Cream Immerses Feet in Moisture
  
  
• February 17, 2009: Newly Published Menopause Study: “Bioidentical” and FDA-Approved Divigel^® (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause

2008

• December 3, 2008: First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-based DHA Now Available
  
  
• November 24, 2008: Upsher-Smith Receives Prestigious Leadership Award
  
  
• September 25, 2008: New Analyses Indicate that Divigel^® (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
  
  
• August 29, 2008: Minneapolis St. Paul Business Journal: Upsher-Smith Expands Drug Development With Investment in Proximagen Neuroscience
  
  
• July 29, 2008: New Economical Alternative Available for the Treatment of Epilepsy
  
  
• July 14, 2008: Proximagen Signs $232 Million Licensing Agreement With Upsher-Smith to Develop PRX1 Programme

2007

• October 3, 2007: New Data Reveal Topical Divigel^® (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
  
  
• August 1, 2007: Upsher-Smith Announces Launch of Divigel^® (estradiol gel) 0.1 Percent for Treatment of Moderate to Severe Hot Flashes Associated With Menopause
  
  
• June 5, 2007: FDA Approves Divigel^® (estradiol gel) 0.1 Percent for Treatment of Moderate to Severe Hot Flashes Associated With Menopause

2006

• 2006 American Podiatric Medical Association's President's Award Presented to Upsher-Smith

2005

• Upsher-Smith launches NEW Vandazole™ Vaginal Gel for bacterial vaginosis
  
  
• Upsher-Smith launches NEW Fortical^® Nasal Spray for postmenopausal osteoporosis
  
  
• Upsher-Smith Laboratories, Inc. and Unigene press release on Fortical^® calcitonin-salmon (rDNA origin)
  
  
• Upsher-Smith Laboratories, Inc. Recognized for Excellence
  
  
• Upsher-Smith Launches Bethanechol Chloride Tablets, USP
  
  
• Upsher-Smith Launches Nyamyc™ (Nystatin Topical Powder, USP)
  
  
• Federal Court Confirms that Upsher-Smith/Schering Settlement Benefited Consumers

2004

• Upsher-Smith receives 2004 DIANA Award for Excellence
  
  
• Upsher-Smith Launches AmLactin^® XL™ Moisturizing Lotion

Careers | Contact Upsher-Smith | Search | Privacy policy | Legal notices

UPSHER-SMITH LABORATORIES, INC., 6701 Evenstad Drive, Maple Grove, MN 55369, 1-800-654-2299
© 2001-2010 UPSHER-SMITH LABORATORIES, INC. All rights reserved.